Hubei Jumpcan (China) Buy Hold or Sell Recommendation
| 600566 Stock | 29.02 0.12 0.42% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Hubei Jumpcan Pharmaceutical is 'Strong Sell'. Macroaxis provides Hubei Jumpcan buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 600566 positions.
Check out Hubei Jumpcan Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Hubei and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Hubei Jumpcan Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Hubei |
Execute Hubei Jumpcan Buy or Sell Advice
The Hubei recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Hubei Jumpcan Pharmaceutical. Macroaxis does not own or have any residual interests in Hubei Jumpcan Pharmaceutical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hubei Jumpcan's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Hubei Jumpcan Trading Alerts and Improvement Suggestions
| Hubei Jumpcan Pharma is unlikely to experience financial distress in the next 2 years | |
| About 62.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Hubei Jumpcan Pharmaceutical sheds 5.6 percent this week, as yearly returns fall more in line with earnings growth - Simply Wall St |
Hubei Jumpcan Returns Distribution Density
The distribution of Hubei Jumpcan's historical returns is an attempt to chart the uncertainty of Hubei Jumpcan's future price movements. The chart of the probability distribution of Hubei Jumpcan daily returns describes the distribution of returns around its average expected value. We use Hubei Jumpcan Pharmaceutical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Hubei Jumpcan returns is essential to provide solid investment advice for Hubei Jumpcan.
| Mean Return | -0.18 | Value At Risk | -5.09 | Potential Upside | 4.57 | Standard Deviation | 3.12 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Hubei Jumpcan historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Hubei Jumpcan Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Dividends Paid | 1.0B | 1.0B | 409.4M | 605.5M | 823.2M | 864.3M | |
| Capital Expenditures | 546.4M | 429.6M | 248.3M | 243.7M | 301.6M | 234.7M | |
| Net Income | 1.6B | 1.3B | 1.7B | 2.2B | 2.8B | 3.0B | |
| Change To Inventory | (20.3M) | 60.0M | (97.2M) | (15.9M) | (98.6M) | (93.7M) | |
| Investments | 89M | (1.1B) | (474.9M) | (1.4B) | (394.2M) | (413.9M) | |
| Change In Cash | 697.9M | 674.3M | 859.8M | 999.9M | 2.9B | 3.1B | |
| Net Borrowings | (538.0) | (172.0) | (1.8M) | 390.7M | 351.6M | 369.2M | |
| Depreciation | 232.5M | 281.0M | 293.8M | 303.9M | 302.7M | 240.4M | |
| Change To Netincome | 10.4M | 14.4M | (120.7M) | 4.2M | 3.8M | 4.0M | |
| End Period Cash Flow | 2.3B | 3.0B | 3.8B | 4.8B | 7.7B | 8.1B | |
| Free Cash Flow | 1.6B | 1.4B | 1.6B | 2.4B | 3.2B | 1.8B | |
| Other Non Cash Items | 33.3M | 40.1M | 45.2M | 39.9M | 19.6M | 34.9M |
Hubei Jumpcan Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Hubei Jumpcan or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Hubei Jumpcan's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Hubei stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | -0.45 | |
σ | Overall volatility | 2.98 | |
Ir | Information ratio | -0.1 |
Hubei Jumpcan Volatility Alert
Hubei Jumpcan Pharmaceutical exhibits very low volatility with skewness of -0.31 and kurtosis of 3.02. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Hubei Jumpcan's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Hubei Jumpcan's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Hubei Jumpcan Fundamentals Vs Peers
Comparing Hubei Jumpcan's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hubei Jumpcan's direct or indirect competition across all of the common fundamentals between Hubei Jumpcan and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hubei Jumpcan or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Hubei Jumpcan's fundamental indicators could also be used in its relative valuation, which is a method of valuing Hubei Jumpcan by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hubei Jumpcan to competition |
| Fundamentals | Hubei Jumpcan | Peer Average |
| Return On Equity | 0.21 | -0.31 |
| Return On Asset | 0.0978 | -0.14 |
| Profit Margin | 0.31 % | (1.27) % |
| Operating Margin | 0.33 % | (5.51) % |
| Current Valuation | 16.23 B | 16.62 B |
| Shares Outstanding | 921.7 M | 571.82 M |
| Shares Owned By Insiders | 62.47 % | 10.09 % |
| Shares Owned By Institutions | 8.79 % | 39.21 % |
| Price To Book | 1.90 X | 9.51 X |
| Price To Sales | 2.97 X | 11.42 X |
| Revenue | 9.65 B | 9.43 B |
| Gross Profit | 7.46 B | 27.38 B |
| EBITDA | 3.01 B | 3.9 B |
| Net Income | 2.82 B | 570.98 M |
| Total Debt | 1.04 B | 5.32 B |
| Book Value Per Share | 15.37 X | 1.93 K |
| Cash Flow From Operations | 3.46 B | 971.22 M |
| Earnings Per Share | 3.03 X | 3.12 X |
| Target Price | 52.36 | |
| Number Of Employees | 5.23 K | 18.84 K |
| Beta | 0.2 | -0.15 |
| Market Capitalization | 26.46 B | 19.03 B |
| Total Asset | 18.14 B | 29.47 B |
| Retained Earnings | 8.85 B | 9.33 B |
| Working Capital | 9.64 B | 1.48 B |
| Net Asset | 18.14 B | |
| Last Dividend Paid | 1.3 |
Hubei Jumpcan Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hubei . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Hubei Jumpcan Buy or Sell Advice
When is the right time to buy or sell Hubei Jumpcan Pharmaceutical? Buying financial instruments such as Hubei Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Hubei Jumpcan in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Machinery Thematic Idea Now
Machinery
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Machinery theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Machinery Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Hubei Stock
Hubei Jumpcan financial ratios help investors to determine whether Hubei Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hubei with respect to the benefits of owning Hubei Jumpcan security.